Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
9.47
+0.08 (0.85%)
At close: Apr 2, 2025, 4:00 PM
9.82
+0.35 (3.74%)
After-hours: Apr 2, 2025, 5:09 PM EDT

Assembly Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-40.18-61.23-93.09-129.86-62.15
Upgrade
Depreciation & Amortization
0.130.450.50.475.91
Upgrade
Loss (Gain) From Sale of Assets
-0.14--1.380.01
Upgrade
Asset Writedown & Restructuring Costs
---41.641.75
Upgrade
Loss (Gain) From Sale of Investments
-3.66-1.590.160.59-0.01
Upgrade
Stock-Based Compensation
3.125.126.595.2421.85
Upgrade
Other Operating Activities
1.423.513.511.31-
Upgrade
Change in Accounts Receivable
0.040.9-0.610.892.14
Upgrade
Change in Accounts Payable
0.12-2.03-0.17-1.942.87
Upgrade
Change in Unearned Revenue
-13.2983.56--6.25-28.06
Upgrade
Change in Other Net Operating Assets
1.18-6.09-1.35-4.1-7.26
Upgrade
Operating Cash Flow
-51.1222.74-84.46-93.4-62.96
Upgrade
Capital Expenditures
-0.03-0.26-0.1-3.1-0.47
Upgrade
Sale of Property, Plant & Equipment
-0.021.52.36-
Upgrade
Sale (Purchase) of Intangibles
-----1.75
Upgrade
Investment in Securities
40.2-68.9189.2427.2570.29
Upgrade
Investing Cash Flow
40.17-69.1490.6426.5268.07
Upgrade
Issuance of Common Stock
29.4513.820.6153.067.6
Upgrade
Financing Cash Flow
29.4513.820.6153.067.6
Upgrade
Net Cash Flow
18.5-32.586.79-13.8212.71
Upgrade
Free Cash Flow
-51.1522.49-84.57-96.49-63.43
Upgrade
Free Cash Flow Margin
-179.33%313.95%--1542.88%-80.18%
Upgrade
Free Cash Flow Per Share
-8.524.91-20.96-26.75-21.48
Upgrade
Cash Income Tax Paid
0.42----
Upgrade
Levered Free Cash Flow
-15.71-8.2-48.91-62.75-10.96
Upgrade
Unlevered Free Cash Flow
-15.71-8.2-48.91-62.75-10.96
Upgrade
Change in Net Working Capital
-9.45-26.89-2.237.6-0.43
Upgrade
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q